AACP
Advantage Alpha Capital Partners Portfolio holdings
AUM
$371M
This Quarter Return
+11.04%
1 Year Return
+16.18%
3 Year Return
+64.49%
5 Year Return
+102.68%
10 Year Return
–
AUM
$371M
AUM Growth
+$371M
(-9.1%)
Cap. Flow
-$76.6M
Cap. Flow
% of AUM
-20.65%
Top 10 Holdings %
Top 10 Hldgs %
18.2%
Holding
167
New
21
Increased
20
Reduced
78
Closed
48
Top Buys
| 1 |
Aaon
AAON
|
$5.57M |
| 2 |
Privia Health
PRVA
|
$3.94M |
| 3 |
Cadre Holdings
CDRE
|
$3.73M |
| 4 |
EXL Service
EXLS
|
$3.56M |
| 5 |
BCPC
Balchem Corporation
BCPC
|
$3.39M |
Top Sells
| 1 |
Grocery Outlet
GO
|
$6.47M |
| 2 |
FTAI Aviation
FTAI
|
$6.15M |
| 3 |
Agilysys
AGYS
|
$5.51M |
| 4 |
ESCO Technologies
ESE
|
$5.37M |
| 5 |
Sterling Infrastructure
STRL
|
$4.72M |
Sector Composition
| 1 | Industrials | 36.07% |
| 2 | Technology | 22.78% |
| 3 | Consumer Discretionary | 12.59% |
| 4 | Healthcare | 10.46% |
| 5 | Materials | 6.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Riot Platforms
RIOT
$4.97B
| $462K | 0.12% |
40,902
-9,736
| -19% | -$110K |
|
102
Collegium Pharmaceutical
COLL
$1.25B
| $459K | 0.12% |
15,531
-3,630
| -19% | -$107K |
|
103
CleanSpark
CLSK
$2.65B
| $405K | 0.11% |
36,753
-8,782
| -19% | -$96.9K |
|
104
MiMedx Group
MDXG
$1.05B
| $403K | 0.11% |
66,124
-15,505
| -19% | -$94.6K |
|
105
Krystal Biotech
KRYS
$4.35B
| $398K | 0.11% |
2,894
-675
| -19% | -$92.8K |
|
106
Protagonist Therapeutics
PTGX
$3.62B
| $385K | 0.1% |
6,972
-1,662
| -19% | -$91.9K |
|
107
Catalyst Pharmaceutical
CPRX
$2.42B
| $352K | 0.09% |
16,200
-3,837
| -19% | -$83.3K |
|
108
Castle Biosciences
CSTL
$673M
| $327K | 0.09% |
16,021
-3,784
| -19% | -$77.3K |
|
109
Dynavax Technologies
DVAX
$1.19B
| $309K | 0.08% |
31,158
-7,285
| -19% | -$72.3K |
|
110
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $305K | 0.08% |
11,020
-2,577
| -19% | -$71.3K |
|
111
Acadia Pharmaceuticals
ACAD
$4.34B
| $273K | 0.07% |
12,643
-2,958
| -19% | -$63.8K |
|
112
Marathon Digital Holdings
MARA
$5.89B
| $236K | 0.06% |
15,069
-3,632
| -19% | -$57K |
|
113
Interparfums
IPAR
$3.65B
| $208K | 0.06% |
+1,584
| New | +$208K |
|
114
Ligand Pharmaceuticals
LGND
$3.25B
| $207K | 0.06% |
+1,823
| New | +$207K |
|
115
Arrowhead Research
ARWR
$3.84B
| $204K | 0.06% |
+12,938
| New | +$204K |
|
116
Aurinia Pharmaceuticals
AUPH
$1.58B
| $204K | 0.06% |
+24,079
| New | +$204K |
|
117
PTC Therapeutics
PTCT
$4.41B
| $204K | 0.06% |
+4,174
| New | +$204K |
|
118
Stoke Therapeutics
STOK
$1.08B
| $203K | 0.05% |
+17,888
| New | +$203K |
|
119
Amicus Therapeutics
FOLD
$2.42B
| $201K | 0.05% |
+35,082
| New | +$201K |
|
|
UCB
120
United Community Banks, Inc.
UCB
$4.01B
| – | – |
-7,711
| Closed | -$217K |
|
|
GTM
121
ZoomInfo Technologies
GTM
$3.31B
| – | – |
-22,364
| Closed | -$235K |
|
122
Xencor
XNCR
$594M
| – | – |
-21,760
| Closed | -$244K |
|
123
WSFS Financial
WSFS
$3.21B
| – | – |
-4,173
| Closed | -$216K |
|
124
Upwork
UPWK
$2.18B
| – | – |
-182,816
| Closed | -$2.39M |
|
125
UMB Financial
UMBF
$9.22B
| – | – |
-2,336
| Closed | -$236K |
|